× Unpublished This content is unpublished, click the edit tab and check "Published" on the bottom of the form. 27. 03.15 13:01 Close share menu European Medicines Agency validates marketing authorisation application for ZINBRYTA (Daclizumab high-yield process) for treatment of MS Source FinanzNachrichten.de Close share menu